Three takeaways from Intel’s PTAB win
Managing IP
MAY 24, 2023
Funders and NPEs say asserting patent portfolios can minimise risk at the USPTO’s PTAB, where procedure remains a controversial topic
Managing IP
MAY 24, 2023
Funders and NPEs say asserting patent portfolios can minimise risk at the USPTO’s PTAB, where procedure remains a controversial topic
JD Supra Law
NOVEMBER 7, 2022
Kilpatrick Townsend’s Babak Kusha recently spoke at the Federal Bar Association’s IP Law Fall Conference 2022 on the topic of “Design Patents for Patent Professionals.” Please see full article below for more information.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
LexBlog IP
JANUARY 3, 2023
The program ( agenda here ) will not only cover PTAB centric topics, but related litigation, appeals to the Federal Circuit, monetization impacts, and patent portfolio development issues.
LexBlog IP
JUNE 2, 2022
AIPLA’s Design Rights Boot Camp is a first-of-its-kind, two-day, comprehensive CLE program designed for both new and experienced IP practitioners who wish to learn about protecting and enforcing designs via all available areas of IP, including design patents, copyrights, and trade dress. Date & Time. James Aquilina. James Aquilina.
LexBlog IP
DECEMBER 18, 2023
In response to public comments submitted in response to its request thereof regarding the “article of manufacture” requirement for design patent eligibility appearing in Title 35, United States Code, Section 171 , and as explained in our previous post , the U.S. a)(I) ] but provides important clarifications.” ” 80 Fed.
LexBlog IP
AUGUST 3, 2023
In the intellectual property sphere, one of the hottest topics surrounding the use of these AI tools is whether the works of art or inventions (including works of industrial design) created using these tools can still be considered the creation of the individual author or designer. This question is of critical importance because the U.S.
The IPKat
MARCH 28, 2022
On 14-16 March, this GuestKat had the opportunity to attend the "Pharma & Biotech Patent Litigation" conference in Amsterdam, which, as many readers will know, not only hosts the Kattenkabinet museum (here below a sample of the oeuvres of the museum.), The IPKat reports on some of the trends and topics from the conference below.
Let's personalize your content